Search results

Order by most recent / most popular / relevance

Results: 1-10 of 65

FDA proposes regulations for stand-alone symbols on medical devices

The Food and Drug Administration (FDA) has proposed revising medical device and biological product labeling regulations "to explicitly allow for the

According to Consumer Product Safety Commission Chair Inez Tenenbaum, the Chronic Hazard Advisory Panel on Phthalates and Phthalate Substitutes

Vermont state senators have voted unanimously in support of legislation (S. 81) that would ban the use of certain purportedly toxic flame-retardant

Because a virtually identical class action pending before a state court is near settlement, a federal court in California has agreed, in the interest

California EPA's Office of Environmental Health Hazard Assessment (OEHHA) has selected several chemicals for review by its Carcinogen Identification

A federal court in New Jersey has imposed an $18-million criminal penalty on Par Pharmaceutical Cos., which entered a guilty plea to one charge of

Plaintiffs in Los Angeles, Las Vegas and New Orleans have reportedly filed lawsuits in the last six months against a compounding pharmacy in Florida

The Sixth Circuit Court of Appeals has determined that when a branded drug manufacturer changes its product labeling and the generic manufacturer

The U.S. Food and Drug Administration (FDA) has issued draft guidance related to accurately labeling medical products not manufactured with natural

The Food and Drug Administration (FDA) recently warned AMARC Enterprises, Inc., a company that manufactures dietary supplements for humans and pets